1. Home
  2. WS vs NVCR Comparison

WS vs NVCR Comparison

Compare WS & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WS
  • NVCR
  • Stock Information
  • Founded
  • WS 1955
  • NVCR 2000
  • Country
  • WS United States
  • NVCR Switzerland
  • Employees
  • WS N/A
  • NVCR N/A
  • Industry
  • WS
  • NVCR Medical/Dental Instruments
  • Sector
  • WS
  • NVCR Health Care
  • Exchange
  • WS Nasdaq
  • NVCR Nasdaq
  • Market Cap
  • WS 1.6B
  • NVCR 1.4B
  • IPO Year
  • WS N/A
  • NVCR 2015
  • Fundamental
  • Price
  • WS $30.08
  • NVCR $13.85
  • Analyst Decision
  • WS Buy
  • NVCR Buy
  • Analyst Count
  • WS 2
  • NVCR 7
  • Target Price
  • WS $35.00
  • NVCR $28.79
  • AVG Volume (30 Days)
  • WS 291.7K
  • NVCR 1.7M
  • Earning Date
  • WS 09-24-2025
  • NVCR 10-30-2025
  • Dividend Yield
  • WS 2.12%
  • NVCR N/A
  • EPS Growth
  • WS N/A
  • NVCR N/A
  • EPS
  • WS 2.35
  • NVCR N/A
  • Revenue
  • WS $3,132,200,000.00
  • NVCR $630,160,000.00
  • Revenue This Year
  • WS $12.50
  • NVCR $6.68
  • Revenue Next Year
  • WS $3.97
  • NVCR $7.01
  • P/E Ratio
  • WS $12.82
  • NVCR N/A
  • Revenue Growth
  • WS N/A
  • NVCR 14.58
  • 52 Week Low
  • WS $21.30
  • NVCR $10.87
  • 52 Week High
  • WS $47.19
  • NVCR $34.13
  • Technical
  • Relative Strength Index (RSI)
  • WS 44.01
  • NVCR 52.57
  • Support Level
  • WS $29.61
  • NVCR $13.57
  • Resistance Level
  • WS $31.46
  • NVCR $14.58
  • Average True Range (ATR)
  • WS 1.07
  • NVCR 0.65
  • MACD
  • WS -0.00
  • NVCR -0.01
  • Stochastic Oscillator
  • WS 28.48
  • NVCR 52.21

About WS Worthington Steel Inc.

Worthington Steel Inc is a processor of carbon flat-rolled steel, a producer of laser-welded solutions, and a provider of electrical steel laminations. The company has manufacturing facilities across the United States, Canada, China, India, Germany and Mexico. It buys coils of steel from primary steel producers and processes them to precise type, thickness, length, width, shape, and surface quality required by customer specifications. The company's product lines and processing capabilities include; carbon flat-rolled steel processing, electrical steel laminations, and tailor welded products. Geographically, the company generates a majority of its revenue from the United States followed by Canada, Mexico, and other regions.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: